Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety

American Journal of Public Health

Volumn 94, Issue 6, 2004, Pages 947-950

  Salmon, Daniel A ^a,b   Moulton, Lawrence H ^a   Halsey, Neal A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ANAPHYLAXIS; DISEASE CONTROL; DRUG SAFETY; GOVERNMENT; HEALTH PROGRAM; HUMAN; INFECTION; LICENSING; PARALYSIS; POLIOMYELITIS; PUBLIC OPINION; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; VACCINATION;

EID: 2542451091     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.94.6.947     Document Type: Review

References (29)

1. Salmon DA, Haber M, Gangarosa EJ, Phillips L, Smith N, Chen RT. Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risks of measles. JAMA. 1999;282:47-53.
2. Murphy TV, Gargiullo PM, Wharton M. More on rotavirus vaccination and intussusception. N Engl J Med. 2002;346:211-212.
3. Hurwitz ES, Holman RC, Nelson DB, Schonberger LB. National surveillance for Guillain-Barré syndrome: January 1978-March 1979. Neurology. 1983;33:150-157.
4. Nathanson N, Langmuir AD. The Cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the Spring of 1955, II: relationship of poliomyelitis to Cutter vaccine. 1963 [Classical Article]. Am J Epidemiol. 1995;142: 109-140.
5. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (PHS). Pediatrics. 1999;104:568-569.
6. Halsey NA. Limiting infant exposure to thimerosal in vaccines and other sources for mercury. JAMA. 1999;282: 1763-1766.
7. Smallpox vaccine adverse events among civilians-United States, January 24-February 18, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:136.
8. Frey SE, Couch RB, Tacket CO, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med. 2002;346:1265-1274.
9. Committee on the Institutional Means for Assessment of Risks to Public Health, National Research Council. Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academy Press; 1983.
10. Committee on Risk Characterization, Commission on Behavioral and Social Sciences and Education, National Research Council. Understanding Risk: Informing Decisions in a Democratic Society. Washington DC: National Academy Press; 1996.
11. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996; 347:921-925.
12. Commission of The European Communities. White paper on food safety in the European Union. Department of Agriculture, Fisheries and Food. Brussels, January 12, 2000. Available at: http://europa.eu.int/comm/dgs/health_consumer/library/pub/pub06_en.pdf. Accessed November 17, 2003.
13. Wood AJ, Stein CM, Woosley R. Making medicines safer-the need for an independent drug safety board. N Engl J Med. 1998;339:1851-1854.
14. Neustadt R, Fineberg H. The Swine Flu Affair: Decision-Making on a Slippery Disease. Washington, DC: Department of Health, Education, and Welfare; 1978.
15. Dowdle WR. Pandemic influenza: confronting a re-emergent threat. The 1976 experience. J Infect Dis. 1997; 176(suppl 1):S69-S72.
16. Murphy TD, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564.
17. Chen RT, Rastogi SC, Mullen JR, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994;12: 542-550.
18. Chen RT, Glasser J, Rhodes P, et al. The Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States. Pediatrics. 1997;99:765-773.
19. Chen RT, DeStefano F, Davis RL, et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull WHO. 2000;78:186-194.
20. Pless R, Casey C, Chen R. Improving the evaluation, management and understanding of adverse events possibly related to immunizations. Available at: http://www.partnersforimmunization.org/cisa.pdf. Accessed November 17, 2003.
21. The National Vaccine Program Office: who we are, what we do, with whom we work, and how to get in touch with us. Centers for Disease Control and Prevention Web site. Available at: http://www.cdc.gov/od/nvpo/who. htm. Accessed November 17, 2003.
22. Stratton K, Gable A, Shetty P, McCormick M, eds. Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington, DC: Institute of Medicine, National Academy Press; 2001.
23. Stratton K, Gable A, Shetty P, McCormick M, eds. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders. Washington, DC: Institute of Medicine, National Academy Press; 2002.
24. Stratton K, Gable A, Shetty P, McCormick M, eds: Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: Institute of Medicine, National Academy Press; 2001.
25. Stratton K, Gable A, Shetty P, McCormick M, eds. Immunization Safety Review: Multiple Immunizations and Immune Dysfunction. Washington, DC: Institute of Medicine, National Academy Press, 2002.
26. Immunization Safety Review Committee: committee roster. Institute of Medicine Web site. Available at: http://www.iom.edu/subpage.asp?id=5981. Accessed September 15, 2003.
27. Chen RT. Vaccine risks: real, perceived and unknown. Vaccine 1999; 17(suppl 3):S41-S46.
28. Lebow CC, Sarsfield LP, Stanley WL, Ettedgui E, Henning G. Safety in the Skies: Personnel and Parties in NTSB Aviation Accident Investigations. Santa Monica, Calif. RAND Institute; 1999.
29. About the NTSB: history and mission. National Transportation Safety Board Web site. Available at: http://www.ntsb.gov/Abt_NTSB/history.htm. Accessed November 17, 2003.